Linked Life Data

6983203

Source:http://linkedlifedata.com/resource/pubmed/id/6983203

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
1983-1-7
pubmed:abstractText
In 88 patients with vaginal Candida albicans a treatment was performed with natamycin vaginal cream for 6 days in daily doses of 5 ml at concentrations 25 mg natamycin/5 ml (Pim-25), 50 mg natamycin/5 ml (Pim-50), and 100 mg natamycin/5 ml (Pim-100). The cure rates, assessed according to negative cultures of swabs 4-7 days after discontinuation of the treatment, were 89.3%, 85.7%, and 96.9% respectively. Swabs taken about 2 weeks after the next menstrual period showed cure rates of 67.9%, 67.9%, and 78.1% respectively. There was no statistically significant difference in the results between the three groups at the 5% level in Fisher's exact test. The recurrence rate was high in all three groups.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
0001-6349
pubmed:author
pubmed:issnType
Print
pubmed:volume
61
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
325-8
pubmed:dateRevised
2004-11-17
pubmed:meshHeading
pubmed:year
1982
pubmed:articleTitle
Vaginal Candida albicans treated with three different concentrations of natamycin (Pimafucin) for 6 days.
pubmed:publicationType
Journal Article